APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sanger Sequencing Service

DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.

Selected research

Market Analysis & Forecast

Global Sanger Sequencing Service Market Analysis and Forecast 2026-2032

1 January 2026198 pages

Choose your research edition.

Industry ResearchSanger Sequencing Service Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Sanger Sequencing Service Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Sanger Sequencing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sanger Sequencing Service Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Sanger Sequencing Service Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.

Global Sanger Sequencing Service key players include Eurofins, Thermofisher, Genewiz, Nucleics, SciGenom Labs, etc. Global top five manufacturers hold a share about 70%. United States is the largest market, with a share about 25%, followed by Europe and China, both with a share about 20 percent. In terms of product, PCR amplicons is the largest segment, with a share about 60%. And in terms of application, the largest application is Institutions, followed by Bioscience Companies, Hospitals.

Report Includes

Read the full market overview

This report presents an overview of global market for Sanger Sequencing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Sanger Sequencing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Sanger Sequencing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sanger Sequencing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sanger Sequencing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Sanger Sequencing Service revenue, projected growth trends, production technology, application and end-user industry.

Sanger Sequencing Service Segment by Company

Source BioScience

GenScript

Thermofisher

Nucleics

GenHunter Corporation

LGC Limited

SciGenom Labs

Fasteris SA

CeMIA SA

Microsynth AG

QuintaraBio

Eurofins

Genewiz

Sanger Sequencing Service Segment by Type

Plasmid DNA

PCR Amplicons

Others

Sanger Sequencing Service Segment by Application

Bioscience Companies

Hospitals

Institutions

Sanger Sequencing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sanger Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sanger Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sanger Sequencing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Sanger Sequencing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Sanger Sequencing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sanger Sequencing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sanger Sequencing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Plasmid DNA Major Player Table 3. PCR Amplicons Major Player Table 4. Others Major Player Table 5. Global Sanger Sequencing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Bioscience Companies Major Player Table 7. Hospitals Major Player Table 8. Institutions Major Player Table 9. Sanger Sequencing Service Industry Trends Table 10. Sanger Sequencing Service Industry Drivers Table 11. Sanger Sequencing Service Industry Opportunities and Challenges Table 12. Sanger Sequencing Service Industry Restraints Table 13. Global Sanger Sequencing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Sanger Sequencing Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Sanger Sequencing Service Market Share by Region (2021-2026) Table 16. Global Sanger Sequencing Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Sanger Sequencing Service Market Share by Region (2027-2032) Table 18. Global Sanger Sequencing Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Sanger Sequencing Service Revenue Market Share by Players (2021-2026) Table 20. Global Sanger Sequencing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Sanger Sequencing Service Key Players Headquarters & Area Served Table 22. Global Sanger Sequencing Service Players, Product Type & Application Table 23. Global Sanger Sequencing Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Sanger Sequencing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Sanger Sequencing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Sanger Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Sanger Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Sanger Sequencing Service Revenue Market Share by Type (2021-2026) Table 30. Global Sanger Sequencing Service Revenue Market Share by Type (2027-2032) Table 31. Global Sanger Sequencing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Sanger Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Sanger Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Sanger Sequencing Service Revenue Market Share by Application (2021-2026) Table 35. Global Sanger Sequencing Service Revenue Market Share by Application (2027-2032) Table 36. Source BioScience Company Information Table 37. Source BioScience Business Overview Table 38. Source BioScience Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Source BioScience Sanger Sequencing Service Product Portfolio Table 40. Source BioScience Recent Development Table 41. GenScript Company Information Table 42. GenScript Business Overview Table 43. GenScript Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. GenScript Sanger Sequencing Service Product Portfolio Table 45. GenScript Recent Development Table 46. Thermofisher Company Information Table 47. Thermofisher Business Overview Table 48. Thermofisher Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Thermofisher Sanger Sequencing Service Product Portfolio Table 50. Thermofisher Recent Development Table 51. Nucleics Company Information Table 52. Nucleics Business Overview Table 53. Nucleics Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Nucleics Sanger Sequencing Service Product Portfolio Table 55. Nucleics Recent Development Table 56. GenHunter Corporation Company Information Table 57. GenHunter Corporation Business Overview Table 58. GenHunter Corporation Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. GenHunter Corporation Sanger Sequencing Service Product Portfolio Table 60. GenHunter Corporation Recent Development Table 61. LGC Limited Company Information Table 62. LGC Limited Business Overview Table 63. LGC Limited Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. LGC Limited Sanger Sequencing Service Product Portfolio Table 65. LGC Limited Recent Development Table 66. SciGenom Labs Company Information Table 67. SciGenom Labs Business Overview Table 68. SciGenom Labs Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. SciGenom Labs Sanger Sequencing Service Product Portfolio Table 70. SciGenom Labs Recent Development Table 71. Fasteris SA Company Information Table 72. Fasteris SA Business Overview Table 73. Fasteris SA Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Fasteris SA Sanger Sequencing Service Product Portfolio Table 75. Fasteris SA Recent Development Table 76. CeMIA SA Company Information Table 77. CeMIA SA Business Overview Table 78. CeMIA SA Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. CeMIA SA Sanger Sequencing Service Product Portfolio Table 80. CeMIA SA Recent Development Table 81. Microsynth AG Company Information Table 82. Microsynth AG Business Overview Table 83. Microsynth AG Sanger Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Microsynth AG Sanger Sequencing Service Product Portfolio Table 85. Microsynth AG Recent Development Table 86. QuintaraBio Company Information Table 87. QuintaraBio Business Overview Table 88. QuintaraBio Sanger Sequencing Service Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. QuintaraBio Sanger Sequencing Service Product Portfolio Table 90. QuintaraBio Recent Development Table 91. Eurofins Company Information Table 92. Eurofins Business Overview Table 93. Eurofins Sanger Sequencing Service Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Eurofins Sanger Sequencing Service Product Portfolio Table 95. Eurofins Recent Development Table 96. Genewiz Company Information Table 97. Genewiz Business Overview Table 98. Genewiz Sanger Sequencing Service Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Genewiz Sanger Sequencing Service Product Portfolio Table 100. Genewiz Recent Development Table 101. North America Sanger Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Sanger Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Sanger Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Sanger Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Sanger Sequencing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Sanger Sequencing Service Revenue by Country (2021-2026) & (US$ Million) Table 107. North America Sanger Sequencing Service Revenue by Country (US$ Million) & (2027-2032) Table 108. Europe Sanger Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Sanger Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Sanger Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Sanger Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Sanger Sequencing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Sanger Sequencing Service Revenue by Country (2021-2026) & (US$ Million) Table 114. Europe Sanger Sequencing Service Revenue by Country (US$ Million) & (2027-2032) Table 115. China Sanger Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 116. China Sanger Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 117. China Sanger Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 118. China Sanger Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Sanger Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 120. Asia Sanger Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 121. Asia Sanger Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 122. Asia Sanger Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Sanger Sequencing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Sanger Sequencing Service Revenue by Region (US$ Million) & (2021-2026) Table 125. Asia Sanger Sequencing Service Revenue by Region (US$ Million) & (2027-2032) Table 126. SAMEA Sanger Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 127. SAMEA Sanger Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 128. SAMEA Sanger Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 129. SAMEA Sanger Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 130. SAMEA Sanger Sequencing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. SAMEA Sanger Sequencing Service Revenue by Country (2021-2026) & (US$ Million) Table 132. SAMEA Sanger Sequencing Service Revenue by Country (US$ Million) & (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Sanger Sequencing Service Image Figure 2. Global Sanger Sequencing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sanger Sequencing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Plasmid DNA Image Figure 5. PCR Amplicons Image Figure 6. Others Image Figure 7. Global Sanger Sequencing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Sanger Sequencing Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Bioscience Companies Image Figure 10. Hospitals Image Figure 11. Institutions Image Figure 12. Global Sanger Sequencing Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Sanger Sequencing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Sanger Sequencing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Sanger Sequencing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Sanger Sequencing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Sanger Sequencing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Sanger Sequencing Service Revenue Market Share by Type (2021-2032) Figure 20. Global Sanger Sequencing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Sanger Sequencing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Sanger Sequencing Service Revenue Market Share by Application (2021-2032) Figure 23. North America Sanger Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Sanger Sequencing Service Revenue Share by Type (2021-2032) Figure 25. North America Sanger Sequencing Service Revenue Share by Application (2021-2032) Figure 26. North America Sanger Sequencing Service Revenue Share by Country (2021-2032) Figure 27. United States Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Sanger Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Sanger Sequencing Service Revenue Share by Type (2021-2032) Figure 32. Europe Sanger Sequencing Service Revenue Share by Application (2021-2032) Figure 33. Europe Sanger Sequencing Service Revenue Share by Country (2021-2032) Figure 34. Germany Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Sanger Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Sanger Sequencing Service Revenue Share by Type (2021-2032) Figure 44. China Sanger Sequencing Service Revenue Share by Application (2021-2032) Figure 45. Asia Sanger Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Sanger Sequencing Service Revenue Share by Type (2021-2032) Figure 47. Asia Sanger Sequencing Service Revenue Share by Application (2021-2032) Figure 48. Asia Sanger Sequencing Service Revenue Share by Region (2021-2032) Figure 49. Japan Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Sanger Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Sanger Sequencing Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Sanger Sequencing Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Sanger Sequencing Service Revenue Share by Country (2021-2032) Figure 59. Brazil Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Sanger Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Plasmid DNA
  • PCR Amplicons
  • Others
Applications
  • Bioscience Companies
  • Hospitals
  • Institutions
Companies covered
  • Source BioScience
  • GenScript
  • Thermofisher
  • Nucleics
  • GenHunter Corporation
  • LGC Limited
  • SciGenom Labs
  • Fasteris SA
  • CeMIA SA
  • Microsynth AG
  • QuintaraBio
  • Eurofins
  • Genewiz

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Sanger Sequencing Service Market by Type
  3. 1.2.1 Global Sanger Sequencing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Plasmid DNA
  5. 1.2.3 PCR Amplicons
  6. 1.2.4 Others
  7. 1.3 Sanger Sequencing Service Market by Application
  8. 1.3.1 Global Sanger Sequencing Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Bioscience Companies
  10. 1.3.3 Hospitals
  11. 1.3.4 Institutions
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Sanger Sequencing Service Market Dynamics
  1. 2.1 Sanger Sequencing Service Industry Trends
  2. 2.2 Sanger Sequencing Service Industry Drivers
  3. 2.3 Sanger Sequencing Service Industry Opportunities and Challenges
  4. 2.4 Sanger Sequencing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Sanger Sequencing Service Market Perspective (2021-2032)
  2. 3.2 Global Sanger Sequencing Service Growth Trends by Region
  3. 3.2.1 Global Sanger Sequencing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Sanger Sequencing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Sanger Sequencing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Sanger Sequencing Service Revenue by Players
  2. 4.1.1 Global Sanger Sequencing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Sanger Sequencing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Sanger Sequencing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Sanger Sequencing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Sanger Sequencing Service Key Players Headquarters & Area Served
  7. 4.4 Global Sanger Sequencing Service Players, Product Type & Application
  8. 4.5 Global Sanger Sequencing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Sanger Sequencing Service Market CR5 and HHI
  11. 4.6.3 2025 Sanger Sequencing Service Tier 1, Tier 2, and Tier 3
5 Sanger Sequencing Service Market Size by Type
  1. 5.1 Global Sanger Sequencing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Sanger Sequencing Service Revenue by Type (2021-2032)
  3. 5.3 Global Sanger Sequencing Service Revenue Market Share by Type (2021-2032)
6 Sanger Sequencing Service Market Size by Application
  1. 6.1 Global Sanger Sequencing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Sanger Sequencing Service Revenue by Application (2021-2032)
  3. 6.3 Global Sanger Sequencing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Source BioScience
  2. 7.1.1 Source BioScience Company Information
  3. 7.1.2 Source BioScience Business Overview
  4. 7.1.3 Source BioScience Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Source BioScience Sanger Sequencing Service Product Portfolio
  6. 7.1.5 Source BioScience Recent Developments
  7. 7.2 GenScript
  8. 7.2.1 GenScript Company Information
  9. 7.2.2 GenScript Business Overview
  10. 7.2.3 GenScript Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 GenScript Sanger Sequencing Service Product Portfolio
  12. 7.2.5 GenScript Recent Developments
  13. 7.3 Thermofisher
  14. 7.3.1 Thermofisher Company Information
  15. 7.3.2 Thermofisher Business Overview
  16. 7.3.3 Thermofisher Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Thermofisher Sanger Sequencing Service Product Portfolio
  18. 7.3.5 Thermofisher Recent Developments
  19. 7.4 Nucleics
  20. 7.4.1 Nucleics Company Information
  21. 7.4.2 Nucleics Business Overview
  22. 7.4.3 Nucleics Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Nucleics Sanger Sequencing Service Product Portfolio
  24. 7.4.5 Nucleics Recent Developments
  25. 7.5 GenHunter Corporation
  26. 7.5.1 GenHunter Corporation Company Information
  27. 7.5.2 GenHunter Corporation Business Overview
  28. 7.5.3 GenHunter Corporation Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 GenHunter Corporation Sanger Sequencing Service Product Portfolio
  30. 7.5.5 GenHunter Corporation Recent Developments
  31. 7.6 LGC Limited
  32. 7.6.1 LGC Limited Company Information
  33. 7.6.2 LGC Limited Business Overview
  34. 7.6.3 LGC Limited Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 LGC Limited Sanger Sequencing Service Product Portfolio
  36. 7.6.5 LGC Limited Recent Developments
  37. 7.7 SciGenom Labs
  38. 7.7.1 SciGenom Labs Company Information
  39. 7.7.2 SciGenom Labs Business Overview
  40. 7.7.3 SciGenom Labs Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 SciGenom Labs Sanger Sequencing Service Product Portfolio
  42. 7.7.5 SciGenom Labs Recent Developments
  43. 7.8 Fasteris SA
  44. 7.8.1 Fasteris SA Company Information
  45. 7.8.2 Fasteris SA Business Overview
  46. 7.8.3 Fasteris SA Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Fasteris SA Sanger Sequencing Service Product Portfolio
  48. 7.8.5 Fasteris SA Recent Developments
  49. 7.9 CeMIA SA
  50. 7.9.1 CeMIA SA Company Information
  51. 7.9.2 CeMIA SA Business Overview
  52. 7.9.3 CeMIA SA Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 CeMIA SA Sanger Sequencing Service Product Portfolio
  54. 7.9.5 CeMIA SA Recent Developments
  55. 7.10 Microsynth AG
  56. 7.10.1 Microsynth AG Company Information
  57. 7.10.2 Microsynth AG Business Overview
  58. 7.10.3 Microsynth AG Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Microsynth AG Sanger Sequencing Service Product Portfolio
  60. 7.10.5 Microsynth AG Recent Developments
  61. 7.11 QuintaraBio
  62. 7.11.1 QuintaraBio Company Information
  63. 7.11.2 QuintaraBio Business Overview
  64. 7.11.3 QuintaraBio Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 QuintaraBio Sanger Sequencing Service Product Portfolio
  66. 7.11.5 QuintaraBio Recent Developments
  67. 7.12 Eurofins
  68. 7.12.1 Eurofins Company Information
  69. 7.12.2 Eurofins Business Overview
  70. 7.12.3 Eurofins Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Eurofins Sanger Sequencing Service Product Portfolio
  72. 7.12.5 Eurofins Recent Developments
  73. 7.13 Genewiz
  74. 7.13.1 Genewiz Company Information
  75. 7.13.2 Genewiz Business Overview
  76. 7.13.3 Genewiz Sanger Sequencing Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Genewiz Sanger Sequencing Service Product Portfolio
  78. 7.13.5 Genewiz Recent Developments
8 North America
  1. 8.1 North America Sanger Sequencing Service Revenue (2021-2032)
  2. 8.2 North America Sanger Sequencing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Sanger Sequencing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Sanger Sequencing Service Revenue by Type (2027-2032)
  5. 8.3 North America Sanger Sequencing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Sanger Sequencing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Sanger Sequencing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Sanger Sequencing Service Revenue by Application (2027-2032)
  9. 8.5 North America Sanger Sequencing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Sanger Sequencing Service Revenue by Country
  11. 8.6.1 North America Sanger Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Sanger Sequencing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Sanger Sequencing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Sanger Sequencing Service Revenue (2021-2032)
  2. 9.2 Europe Sanger Sequencing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Sanger Sequencing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Sanger Sequencing Service Revenue by Type (2027-2032)
  5. 9.3 Europe Sanger Sequencing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Sanger Sequencing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Sanger Sequencing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Sanger Sequencing Service Revenue by Application (2027-2032)
  9. 9.5 Europe Sanger Sequencing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Sanger Sequencing Service Revenue by Country
  11. 9.6.1 Europe Sanger Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Sanger Sequencing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Sanger Sequencing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Sanger Sequencing Service Revenue (2021-2032)
  2. 10.2 China Sanger Sequencing Service Revenue by Type (2021-2032)
  3. 10.2.1 China Sanger Sequencing Service Revenue by Type (2021-2026)
  4. 10.2.2 China Sanger Sequencing Service Revenue by Type (2027-2032)
  5. 10.3 China Sanger Sequencing Service Revenue Share by Type (2021-2032)
  6. 10.4 China Sanger Sequencing Service Revenue by Application (2021-2032)
  7. 10.4.1 China Sanger Sequencing Service Revenue by Application (2021-2026)
  8. 10.4.2 China Sanger Sequencing Service Revenue by Application (2027-2032)
  9. 10.5 China Sanger Sequencing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Sanger Sequencing Service Revenue (2021-2032)
  2. 11.2 Asia Sanger Sequencing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Sanger Sequencing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Sanger Sequencing Service Revenue by Type (2027-2032)
  5. 11.3 Asia Sanger Sequencing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Sanger Sequencing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Sanger Sequencing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Sanger Sequencing Service Revenue by Application (2027-2032)
  9. 11.5 Asia Sanger Sequencing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Sanger Sequencing Service Revenue by Country
  11. 11.6.1 Asia Sanger Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Sanger Sequencing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Sanger Sequencing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Sanger Sequencing Service Revenue (2021-2032)
  2. 12.2 SAMEA Sanger Sequencing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Sanger Sequencing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Sanger Sequencing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Sanger Sequencing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Sanger Sequencing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Sanger Sequencing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Sanger Sequencing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Sanger Sequencing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Sanger Sequencing Service Revenue by Country
  11. 12.6.1 SAMEA Sanger Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Sanger Sequencing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Sanger Sequencing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst